Bioanalytical Testing Services Market To Witness A Significant Growth Of USD 7,645.7 Million By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg5icgACIFS-I0THzaE8O7_dZ5Fc1FHXGJ-16rC8l9myZtGwUbDpWFe58BLFp_liKl4xY4ZrAQeBi6VCeGY3OsZwXbD4PI8phDey01D5Mv4brpxBVD7l9TPdFnK0ySNHJuC67prwdr7HhwMh1xM7CoVPrO3RX3l5oZiVFDLjkibCsJdEShqOjtMjwI_anPI/s320/Bioanalytical%20Testing%20Services%20Market.png)
San Francisco, 28 Nov 2023: The Report Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (Bioavailability, Bioequivalance), By Workflow (Sample Analysis, Sample Preparation), And Segment Forecasts, 2023 - 2030 The global bioanalytical testing services market size is expected to reach USD 7,645.7 million by 2030, according to a new report by Grand View Research, Inc. registering a CAGR of 8.7% over the forecast period. The increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted the demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe. Furthermore, the growing demand for pharmaceutical products a